SEGMENT AND REGIONAL SALES INFORMATION (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Segment Reporting [Abstract] |
|
| Segment Information Disclosure |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2026 | | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Other | | Total Consolidated | | Depreciation and amortization expense | $ | 52 | | | $ | 36 | | | $ | 25 | | | $ | 16 | | | $ | 129 | | | $ | 2 | | | $ | 131 | | | Capital expenditures | 55 | | | 16 | | | 17 | | | 7 | | | 95 | | | 8 | | | 103 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2025 | | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Other | | Total Consolidated | | Depreciation and amortization expense | $ | 50 | | | $ | 35 | | | $ | 24 | | | $ | 16 | | | $ | 125 | | | $ | 1 | | | $ | 126 | | | Capital expenditures | 97 | | | 15 | | | 19 | | | 8 | | | 139 | | | 8 | | | 147 | |
|
| Reconciliation of Operating Profit (Loss) from Segments to Consolidated |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2026 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 715 | | | $ | 739 | | | $ | 495 | | | $ | 225 | | | $ | 2,174 | | | | | | | | | | | | | Cost of sales | 557 | | | 536 | | | 480 | | | 161 | | | 1,734 | | | | | | | | | | | | | Selling, general and administrative expenses | 71 | | | 50 | | | 28 | | | 15 | | | 164 | | Other segment items (1) | 18 | | | 11 | | | 5 | | | 4 | | | 38 | | Adjusted EBIT | 69 | | | 142 | | | (18) | | | 45 | | | 238 | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated "Earnings before income taxes" ("EBT"): | | Other adjusted EBIT (2) | | | | | | | | | (38) | | | Non-core items impacting EBIT | | | | | Cost of sales impact from restructuring activities (3) | | | | (3) | | Asset impairments, restructuring, and other charges, net (3) | | | | (9) | | | | | | | | | | | | | Net interest expense | | | | (52) | | | Consolidated EBT | | | | | | | | | $ | 136 | | | | | | | | | | | | | First Quarter 2025 | | (Dollars in millions) | Advanced Materials | | Additives & Functional Products | | Chemical Intermediates | | Fibers | | Total Operating Segments | | Sales | $ | 719 | | | $ | 733 | | | $ | 545 | | | $ | 288 | | | $ | 2,285 | | | | | | | | | | | | | Cost of sales | 511 | | | 526 | | | 492 | | | 176 | | | 1,705 | | | Selling, general and administrative expenses | 69 | | | 51 | | | 28 | | | 19 | | | 167 | | Other segment items (1) | 23 | | | 15 | | | 6 | | | 5 | | | 49 | | | Adjusted EBIT | 116 | | | 141 | | | 19 | | | 88 | | | 364 | | | | | | | | | | | | | Reconciliation of segment Adjusted EBIT to consolidated EBT: | | Other adjusted EBIT (2) | | | | | | | | | (53) | | | Non-core items impacting EBIT | | | | | | | | | | Asset impairments, restructuring, and other charges, net (3) | | | | (9) | | | | | | | | | | | | | | | | | | | | | | | Net interest expense | | | | | | | | | (49) | | | Consolidated EBT | | | | | | | | | $ | 253 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (1)Other segment items for each reportable segment includes R&D expenses, other components of post-employment (benefit) cost, net and other (income) charges, net. (2)Other is not considered an operating segment. Other includes sales and costs from growth initiatives and businesses, R&D costs, pension and other postretirement benefit plans income (expense), net, and other income (charges), net that are not identifiable to an operating segment. (3)See Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", for a description of included items. |
|
| Reconciliation of Assets from Segment to Consolidated |
| | | | | | | | | | | | | | | | | (Dollars in millions) | First Quarter | | | | Sales by Segment | 2026 | | 2025 | | | | | | Advanced Materials | $ | 715 | | | $ | 719 | | | | | | | Additives & Functional Products | 739 | | | 733 | | | | | | | Chemical Intermediates | 495 | | | 545 | | | | | | | Fibers | 225 | | | 288 | | | | | | | Total Sales by Operating Segment | 2,174 | | | 2,285 | | | | | | | Other | 3 | | | 5 | | | | | | | Total Sales | $ | 2,177 | | | $ | 2,290 | | | | | |
| | | | | | | | | | | | | | | | | (Dollars in millions) | March 31, 2026 | | December 31, 2025 | Assets by Segment (1) | | | | | Advanced Materials | $ | 5,783 | | | $ | 5,705 | | Additives & Functional Products | 4,748 | | | 4,668 | | Chemical Intermediates | 1,731 | | | 1,646 | | | Fibers | 1,027 | | | 1,020 | | | Total Assets by Operating Segment | 13,289 | | | 13,039 | | | Corporate Assets | 1,933 | | | 1,820 | | | Total Assets | $ | 15,222 | | | $ | 14,859 | |
(1)Segment assets include accounts receivable, inventory, fixed assets, goodwill, and intangible assets.
|